Fertility and Pregnancy-Related Issues in Young BRCA Carriers With Breast Cancer.

Magaton, Isotta Martha; Arecco, Luca; Mariamidze, Elene; Jankovic, Kristina; Stana, Mihaela; Buzzatti, Giulia; Trevisan, Lucia; Scavone, Graziana; Ottonello, Silvia; Fregatti, Piero; Massarotti, Claudia; von Wolff, Michael; Lambertini, Matteo (2024). Fertility and Pregnancy-Related Issues in Young BRCA Carriers With Breast Cancer. Breast cancer, 18(11782234241261429) 10.1177/11782234241261429

[img]
Preview
Text
magaton-et-al-2024-fertility-and-pregnancy-related-issues-in-young-brca-carriers-with-breast-cancer.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC).

Download (303kB) | Preview

Approximately 10% to 15% of breast cancer cases in young women are diagnosed in patients harbouring germline (g) pathogenic or likely pathogenic variants (PVs) in the BReast CAncer 1 (BRCA1) or BReast CAncer 2 (BRCA2) genes. Preclinical and clinical studies showed a potential negative effect of germline BRCA1/2 (gBRCA1/2) PVs on ovarian reserve and reproductive potential, even before starting anticancer therapies. The aim of this article is to summarize the current literature on the fertility potential of young gBRCA1/2 PVs carriers with breast cancer and the risk of gonadotoxicity associated with anticancer treatments. Moreover, we describe the available evidence on the efficacy of fertility preservation techniques in young gBRCA1/2 PVs carriers and the safety data on having a pregnancy after breast cancer treatment.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Gynaecology

UniBE Contributor:

Magaton, Isotta Martha

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1178-2234

Language:

English

Submitter:

Pubmed Import

Date Deposited:

17 Jun 2024 16:29

Last Modified:

18 Jun 2024 04:09

Publisher DOI:

10.1177/11782234241261429

PubMed ID:

38882447

Uncontrolled Keywords:

Germline BRCA1/2 pathogenic variants anti-Müllerian hormone fertility oncofertility pregnancy

BORIS DOI:

10.48350/197891

URI:

https://boris.unibe.ch/id/eprint/197891

Actions (login required)

Edit item Edit item
Provide Feedback